ReviR Therapeutics

ReviR Therapeutics is an AI-enabled biotechnology company developing small molecule RNA modulators for neurogenetic diseases. Its VoyageR platform focuses on creating non-invasive, orally administered genetic therapies that regulate RNA splicing and influence protein expression, addressing the limitations of many current genetic therapy modalities. This approach targets 'undruggable' proteins by targeting RNA upstream of protein synthesis.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $30M

Date: 26-Jul-2024

Investors: Lapam Capital, CDH Investments, 5Y Capital, Yael Capital, XtalPi, Charcot-Marie Tooth Research Foundation (CMTRF)

Markets: Biotechnology, AI, RNA Therapeutics, Neurodegenerative Diseases, Rare Genetic Disorders

HQ: South San Francisco, California, United States

Founded: 2021

Website: https://www.revirtx.com/

LinkedIn: https://www.linkedin.com/company/revir-therapeutics

Twitter: https://twitter.com/ReVir_Inc

Instagram: